# Donor Enriched Activated NK Cell Infusion Post Haploidentical Stem Cell Transplant for Refractory Myeloid Malignancies

> **NCT05375253** · PHASE1 · WITHDRAWN · sponsor: **University of Nebraska**

## Conditions studied

- Leukemia

## Interventions

- **BIOLOGICAL:** Donor Enriched Activated Natural Killer Cell Infusion

## Key facts

- **NCT ID:** NCT05375253
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-04-12
- **Primary completion:** 2023-04-12
- **Final completion:** 2023-04-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI has left institution and is taking the study with him.
- **Last updated:** 2024-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05375253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05375253, "Donor Enriched Activated NK Cell Infusion Post Haploidentical Stem Cell Transplant for Refractory Myeloid Malignancies". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05375253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*